During the recent session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares were 0.44 million, with the beta value of the company hitting -0.03. The 52-week high for the RVPH share is $5.67, that puts it down -357.26 from that peak though still a striking 51.61% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $41.47M, and the average intraday trading volume over the past 10 days was 1.0 million shares, and the average trade volume was 455.24K shares over the past three months.
Reviva Pharmaceuticals Holdings Inc (RVPH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. RVPH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
The stock’s 5-day price performance is 10.22%, and it has moved by 8.77% in 30 days. Based on these gigs, the overall price performance for the year is -72.63%. The short interest in Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is 5.3 million shares and it means that shorts have 19.04 day(s) to cover.
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
Statistics show that Reviva Pharmaceuticals Holdings Inc has outperformed its competitors in share price, compared to the industry in which it operates. Reviva Pharmaceuticals Holdings Inc (RVPH) shares have gone down -18.95% during the last six months, with a year-to-date growth rate more than the industry average at 40.61% against 16.60.
While earnings are projected to return 41.33% in 2024.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Reviva Pharmaceuticals Holdings Inc insiders own 14.79% of total outstanding shares while institutional holders control 30.07%, with the float percentage being 35.28%. WOODLINE PARTNERS LP is the largest shareholder of the company, while 35.0 institutions own stock in it. As of 2024-06-30, the company held over 1.59 million shares (or 6.6273% of all shares), a total value of $2.04 million in shares.
The next largest institutional holding, with 1.24 million shares, is of MILLENNIUM MANAGEMENT LLC’s that is approximately 5.1656% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.59 million.
Also, the Mutual Funds coming in first place with the largest holdings of Reviva Pharmaceuticals Holdings Inc (RVPH) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 700.44 shares. This amounts to just over 2.09 percent of the company’s overall shares, with a $0.87 million market value. The same data shows that the other fund manager holds slightly less at 312.3, or about 0.93% of the stock, which is worth about $0.39 million.
